237 related articles for article (PubMed ID: 18237197)
21. Integrin cleavage facilitates cell surface-associated proteolysis required for vascular smooth muscle cell invasion.
Kappert K; Meyborg H; Baumann B; Furundzija V; Kaufmann J; Graf K; Stibenz D; Fleck E; Stawowy P
Int J Biochem Cell Biol; 2009 Jul; 41(7):1511-7. PubMed ID: 19166965
[TBL] [Abstract][Full Text] [Related]
22. MMP-1: the elder of the family.
Pardo A; Selman M
Int J Biochem Cell Biol; 2005 Feb; 37(2):283-8. PubMed ID: 15474975
[TBL] [Abstract][Full Text] [Related]
23. Targeting the Hemopexin-like Domain of Latent Matrix Metalloproteinase-9 (proMMP-9) with a Small Molecule Inhibitor Prevents the Formation of Focal Adhesion Junctions.
Alford VM; Kamath A; Ren X; Kumar K; Gan Q; Awwa M; Tong M; Seeliger MA; Cao J; Ojima I; Sampson NS
ACS Chem Biol; 2017 Nov; 12(11):2788-2803. PubMed ID: 28945333
[TBL] [Abstract][Full Text] [Related]
24. APMA (4-aminophenylmercuric acetate) activation of stromelysin-1 involves protein interactions in addition to those with cysteine-75 in the propeptide.
Galazka G; Windsor LJ; Birkedal-Hansen H; Engler JA
Biochemistry; 1996 Aug; 35(34):11221-7. PubMed ID: 8780527
[TBL] [Abstract][Full Text] [Related]
25. The helping hand of collagenase-3 (MMP-13): 2.7 A crystal structure of its C-terminal haemopexin-like domain.
Gomis-Rüth FX; Gohlke U; Betz M; Knäuper V; Murphy G; López-Otín C; Bode W
J Mol Biol; 1996 Dec; 264(3):556-66. PubMed ID: 8969305
[TBL] [Abstract][Full Text] [Related]
26. MT1-MMP hemopexin domain exchange with MT4-MMP blocks enzyme maturation and trafficking to the plasma membrane in MCF7 cells.
Atkinson SJ; Roghi C; Murphy G
Biochem J; 2006 Aug; 398(1):15-22. PubMed ID: 16686598
[TBL] [Abstract][Full Text] [Related]
27. Protein disulfide isomerase-mediated disulfide bonds regulate the gelatinolytic activity and secretion of matrix metalloproteinase-9.
Khan MM; Simizu S; Suzuki T; Masuda A; Kawatani M; Muroi M; Dohmae N; Osada H
Exp Cell Res; 2012 May; 318(8):904-14. PubMed ID: 22406264
[TBL] [Abstract][Full Text] [Related]
28. Cleavage of denatured natural collagen type II by neutrophil gelatinase B reveals enzyme specificity, post-translational modifications in the substrate, and the formation of remnant epitopes in rheumatoid arthritis.
Van den Steen PE; Proost P; Grillet B; Brand DD; Kang AH; Van Damme J; Opdenakker G
FASEB J; 2002 Mar; 16(3):379-89. PubMed ID: 11874987
[TBL] [Abstract][Full Text] [Related]
29. Proteolytic action of kallikrein-related peptidase 7 produces unique active matrix metalloproteinase-9 lacking the C-terminal hemopexin domains.
Ramani VC; Kaushal GP; Haun RS
Biochim Biophys Acta; 2011 Aug; 1813(8):1525-31. PubMed ID: 21616098
[TBL] [Abstract][Full Text] [Related]
30. Gelatinase B in multiple sclerosis and experimental autoimmune encephalomyelitis.
Dubois B; Opdenakker G; Carton H
Acta Neurol Belg; 1999 Mar; 99(1):53-6. PubMed ID: 10218093
[TBL] [Abstract][Full Text] [Related]
31. Matrix metalloproteinase-1 takes advantage of the induced fit mechanism to cleave the triple-helical type I collagen molecule.
O'Farrell TJ; Guo R; Hasegawa H; Pourmotabbed T
Biochemistry; 2006 Dec; 45(51):15411-8. PubMed ID: 17176063
[TBL] [Abstract][Full Text] [Related]
32. The matrix metalloproteinase 9 (mmp-9) hemopexin domain is a novel gelatin binding domain and acts as an antagonist.
Roeb E; Schleinkofer K; Kernebeck T; Pötsch S; Jansen B; Behrmann I; Matern S; Grötzinger J
J Biol Chem; 2002 Dec; 277(52):50326-32. PubMed ID: 12384502
[TBL] [Abstract][Full Text] [Related]
33. Modulation of the proteolytic activity of matrix metalloproteinase-2 (gelatinase A) on fibrinogen.
Monaco S; Gioia M; Rodriguez J; Fasciglione GF; Di Pierro D; Lupidi G; Krippahl L; Marini S; Coletta M
Biochem J; 2007 Mar; 402(3):503-13. PubMed ID: 17087661
[TBL] [Abstract][Full Text] [Related]
34. Alendronate promotes plasmin-mediated MMP-9 inactivation by exposing cryptic plasmin degradation sites within the MMP-9 catalytic domain.
Farina AR; Cappabianca L; Di Ianni N; Ruggeri P; Ragone M; Merolle S; Gulino A; Mackay AR
FEBS Lett; 2012 Jul; 586(16):2366-74. PubMed ID: 22677171
[TBL] [Abstract][Full Text] [Related]
35. Molecular structures and dynamics of the stepwise activation mechanism of a matrix metalloproteinase zymogen: challenging the cysteine switch dogma.
Rosenblum G; Meroueh S; Toth M; Fisher JF; Fridman R; Mobashery S; Sagi I
J Am Chem Soc; 2007 Nov; 129(44):13566-74. PubMed ID: 17929919
[TBL] [Abstract][Full Text] [Related]
36. Characterization of the mechanisms by which gelatinase A, neutrophil collagenase, and membrane-type metalloproteinase MMP-14 recognize collagen I and enzymatically process the two alpha-chains.
Gioia M; Monaco S; Fasciglione GF; Coletti A; Modesti A; Marini S; Coletta M
J Mol Biol; 2007 May; 368(4):1101-13. PubMed ID: 17379243
[TBL] [Abstract][Full Text] [Related]
37. Activation of progelatinase A by mammalian legumain, a recently discovered cysteine proteinase.
Chen JM; Fortunato M; Stevens RA; Barrett AJ
Biol Chem; 2001 May; 382(5):777-83. PubMed ID: 11517930
[TBL] [Abstract][Full Text] [Related]
38. Multiple sites of the propeptide region of human stromelysin-1 are required for maintaining a latent form of the enzyme.
Freimark BD; Feeser WS; Rosenfeld SA
J Biol Chem; 1994 Oct; 269(43):26982-7. PubMed ID: 7929438
[TBL] [Abstract][Full Text] [Related]
39. Propeptide glycosylation and galectin-3 binding decrease proteolytic activation of human proMMP-9/progelatinase B.
Boon L; Ugarte-Berzal E; Martens E; Vandooren J; Rybakin V; Colau D; Gordon-Alonso M; van der Bruggen P; Stöcker W; Becker-Pauly C; Witters P; Morava E; Jaeken J; Proost P; Opdenakker G
FEBS J; 2019 Mar; 286(5):930-945. PubMed ID: 30422384
[TBL] [Abstract][Full Text] [Related]
40. Role of Wnt-5A in interleukin-1beta-induced matrix metalloproteinase expression in rabbit temporomandibular joint condylar chondrocytes.
Ge X; Ma X; Meng J; Zhang C; Ma K; Zhou C
Arthritis Rheum; 2009 Sep; 60(9):2714-22. PubMed ID: 19714632
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
